K221616 is an FDA 510(k) clearance for the Patient Monitor, models LMPLUS-12, LMPLUS-15 and LMPLUS-17. This device is classified as a Monitor, Physiological, Patient(with Arrhythmia Detection Or Alarms) (Class II - Special Controls, product code MHX).
Submitted by Caf Medical Solutions, Inc. (Hockley, US). The FDA issued a Cleared decision on August 1, 2022, 59 days after receiving the submission on June 3, 2022.
This device falls under the Cardiovascular FDA review panel. Regulated under 21 CFR 870.1025.